STUDY OF FIBROSIS PATHWAYS (TGF-Β AND WNT SIGNALING) AS THERAPEUTIC TARGETS IN CHRONIC KIDNEY DISEASE. MSW Management Journal, [S. l.], v. 36, n. 1s, p. 2466–2470, 2026. DOI: 10.7492/6nvwdg38. Disponível em: https://mswmanagementj.com/home/article/view/2648.. Acesso em: 3 may. 2026.